Karly Rowe

Karly Rowe is responsible for the Patient Access, Identity, and Care Management product portfolios at Experian Health. With a diverse background across credit, retail, and healthcare, Karly is responsible for finding new ways to leverage Experian’s data and analytical capabilities to develop new, innovative solutions for the healthcare industry. Karly holds a Master of Business Administration from Arizona State University and a bachelor’s degree in Marketing Management and Retail Management from Syracuse University. She resides in Scottsdale, Arizona with her husband and two sons.

Experian Health is crunching data for approximately 11,000 healthcare organizations representing 500,000+ providers and covering almost 60% of the entire U.S. healthcare market. Karly, on behalf of Experian Health, can help bring interpretation and insight to a wide range of emerging news topics, such as:

•       Accelerating Digital Health Transactions – How technology products like online scheduling and patient portals are quickly evolving, and the ongoing commitments to address issues like medical fraud are being addressed
•       Covid 19 & Data Management – How ongoing data duplication errors continue to disrupt the healthcare industry, which is an unchartered territory for many in the healthcare industry
•       The Impact of Duplicate Records – How can providers collect, integrate and apply the massive amount of medical data coming from an enormous wave of patient-generated information
•       Standardize & Improve – How standardizing records could improve healthcare outcomes and help avoid a future crisis of confusion and the potentially crippling effects of duplicate and inaccurate health records
•       Social determinants of health (SDOH) – How non-medical factors of healthcare account for up to 80 percent of health outcomes. Experian Health data and its CORE heat map can give government, public health officials and healthcare systems a more holistic view of patients that can lead to better health outcomes, including equitable distribution of COVID vaccines.